The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

Is ENPH stock a worthwhile purchase following such a considerable drop? This steep decrease for Enphase Energy stands out ...

DocuSign has experienced a notable decline in its stock price, dropping by 15.61% over the past week. This movement comes amidst a series of analyst reports maintaining a ‘Hold ...

Key Takeaways Docusign's first-quarter billings missed estimates, and it lowered its full-year billings outlook.The ...

The company lowered its full-year earnings forecast to $14.58 to $14.78 per share, down from prior guidance of $14.95 to ...

On a year-to-date basis, DOCU has gained nearly 4 %, outperforming the broader S&P 500 Index, which rose 1.51% during the ...

Sebastian Ng / SOPA Images / LightRocket via Getty Images Lululemon Athletica shares were off about 1% Wednesday as Morgan Stanley cut its target price for the athleisure company's stock.

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some ...

The Stock Declines as the Truth is Revealed On May 1, 2025, Organon announced that management reset the Company's dividend payout from $0.28 per share to $0.02 per share. Organon's CEO explained that ...

Target has to deliver better results or the stock could keep falling as investors lose patience. But value investors looking at Target's 53 consecutive years of dividend raises and 4.7% yield may ...

We rate DocuSign a buy with a $130 PT ... Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such ...

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign ...